Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04569422
Other study ID # 2020-002-01
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 1, 2020
Est. completion date May 21, 2021

Study information

Verified date September 2020
Source Aier School of Ophthalmology, Central South University
Contact Yuanyuan Yin, bachelor
Phone 18621755180
Email 815969138@qq.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In this study, there were differences in patients' demands for ephedrine during meibomian gland massage and whether it would affect patients' poor comfort. Therefore, we needed to collect patients' pain grades during meibomian gland massage


Description:

Meibomian gland dysfunction is a common eye disease that may be asymptomatic or painful and itchy in the early stages, requiring early daily care and medication. And meibomian gland massage is a very important step in the treatment. Meibomian gland massage is massaging along the direction of meibomian gland drainage to push out secretions that cannot be discharged by themselves, improve meibomian gland function, and delay the development of meibomian gland dysfunction.Meibomian gland dysfunction is a common eye disease that may be asymptomatic or painful and itchy in the early stages, requiring early daily care and medication. And meibomian gland massage is a very important step in the treatment. Meibomian gland massage is massaging along the direction of meibomian gland drainage to push out secretions that cannot be discharged by themselves, improve meibomian gland function, and delay the development of meibomian gland dysfunction.Meibomian gland dysfunction is a common eye disease that may be asymptomatic or painful and itchy in the early stages, requiring early daily care and medication. And meibomian gland massage is a very important step in the treatment. Meibomian gland massage is massaging along the direction of meibomian gland drainage to push out secretions that cannot be discharged by themselves, improve meibomian gland function, and delay the development of meibomian gland dysfunction.

Methods: We selected dry eye patients who visited dry eye clinic of Aier Eye Hospital from June 2020 to March 2021 to conduct questionnaire survey and analysis with pain scaleMethods: We selected dry eye patients who visited dry eye clinic of Aier Eye Hospital from June 2020 to March 2021 to conduct questionnaire survey and analysis with pain scale Group: Divided into ephedrine drop group and artificial tear drop group Research tool: Pain rating scale


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date May 21, 2021
Est. primary completion date March 21, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

Healthy people with no chronic disease

Exclusion Criteria:

People with chronic disease

Study Design


Related Conditions & MeSH terms

  • Meibomian Gland Massage is Important to Delay the Development of Meibomian Gland Dysfunction

Intervention

Drug:
Benoxyl
reduce pain

Locations

Country Name City State
China Aier School of Ophthalmology, Central South University Changsha Hunan

Sponsors (1)

Lead Sponsor Collaborator
Aier School of Ophthalmology, Central South University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Undifferrentiated There was no difference in the effect of obuvacaine hydrochloride on the comfort of meibomian gland massage patients 2020.01-2020.09